SAN DIEGO, March 15, 2019 /PRNewswire/ -- Johnson
Fistel, LLP announces that it has filed a class action lawsuit
on behalf of all those who purchased or otherwise acquired Diplomat
Pharmacy, Inc. ("Diplomat") (NYSE: DPLO) common stock during the
period between February 26, 2018
through February 21, 2019, inclusive
(the "Class Period"). This action was filed in the United States District Court for the
Northern District of Illinois,
case No. 1:19-cv-01735.
The Private Securities Litigation Reform Act of 1995 permits any
investor who purchased or otherwise acquired Diplomat securities
during the Class Period to seek appointment as lead plaintiff. A
lead plaintiff acts on behalf of all other class members in
directing the litigation. The lead plaintiff can select a law firm
of its choice. An investor's ability to share in any potential
future recovery is not dependent upon serving as lead plaintiff. If
you wish to serve as lead plaintiff, you must move the Court no
later April 25, 2019. If you
wish to discuss this action or have any questions concerning this
notice or your rights or interests, please contact Jim Baker (jimb@johnsonfistel.com) at
619-814-4471. If emailing, please include a phone
number. Additionally, you can [click here to join this
action]. There is no cost or obligation to you.
The complaint alleges that defendants made false and misleading
statements and failed to disclose that: (1) Diplomat had downplayed
its success in integrating and growing its PBM business, which
included LDI Integrated and National Pharmaceutical, two companies
Diplomat had acquired in late 2017; (2) consequently, Diplomat
would need to record a non-cash impairment charge upwards of
approximately $630 million relating
to its PBM business and these 2017 acquisitions; (3) due to the
foregoing, Diplomat would withdraw its preliminary 2019 full-year
outlook issued less than seven weeks prior; and (4) as a result,
defendants' statements about Diplomat's business, operations and
prospects were materially false and misleading and lacked a
reasonable basis at all relevant times.
Plaintiff seeks to recover damages on behalf of all those who
purchased or otherwise acquired Diplomat securities during the
Class Period.
About Johnson Fistel,
LLP:
Johnson Fistel, LLP is a nationally
recognized shareholder rights law firm with offices in California, New
York, and Georgia. The firm
represents individual and institutional investors in shareholder
derivative and securities class action lawsuits. For more
information about the firm and its attorneys, please visit
https://www.johnsonfistel.com. Attorney advertising. Past results
do not guarantee future outcomes.
Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
jimb@johnsonfistel.com
View original
content:http://www.prnewswire.com/news-releases/johnson-fistel-llp-files-class-action-suit-against-diplomat-pharmacy-inc-300813305.html
SOURCE Johnson Fistel, LLP